SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-24-001484
Filing Date
2024-02-13
Accepted
2024-02-13 16:34:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 APPLIED THERAPEUTICS, INC. p24-0811sc13g.htm SC 13G 62332
2 JOINT ACQUISITION STATEMENT p24-0811exhibit99.htm EX-99.1 4046
  Complete submission text file 0000902664-24-001484.txt   67927
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Subject) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91017 | Film No.: 24626677
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 632 BROADWAY SUITE 602 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 602 NEW YORK NY 10012 6469894000
Vestal Point Capital, LP (Filed by) CIK: 0001974915 (see all company filings)

IRS No.: 922296021 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G